MENS Bathi mangsa ngarep Jyong Biotech Limited

Simbol resmi perusahaan Jyong Biotech Limited (MENS)

Jyong Biotech Ltd relies on a compact staff of scientists and compliance experts. Expected profit margins reflect a trend driven by an out-licensing model for urological drugs to minimize costs. High barriers to entry and patent protection create conditions for a monopoly. The value of shows the current metric value, capturing the final point of the business yield forecast.

jyongbio.com (MENS): Bathi resik sing dikarepake saka 04.07.2022 nganti 18.11.2026

Jyong Biotech Corp - rincian analitis lan metrik utama (MENS)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:MENS, Jyong Biotech
Produk dadi Jyong Biotech Limited

This indicator aggregates the dynamics of market expectations regarding future cash flows, allowing investors to assess the fundamental value of the asset between official report publications. When analyzing the expected bottom-line financial result, one must consider the impact of Jyong Biotech Ltd (MENS) expenditures on eco-friendly extraction and sustainable raw material collection, which directly determine the final profitability of plant-based pharmaceuticals.

Analisis pesaing Jyong Biotech Ltd

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|LGND (Ligand Corp) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Amneal Pharmaceuticals, Inc. AMRX|Perrigo (PRGO) - Bathi resik sing dikarepake|ALVO: Bathi mangsa ngarep|Liquidia - Bathi resik mangsa ngarep|GLPG: Proyeksi bathi mangsa ngarep|ANI Pharma - Penghasilan resik sing dikarepake|MNKD (MannKind Corp) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake amphastar.com AMPH|Bathi sing dikarepake Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Penghasilan resik sing dikarepake|Theravance Biopharma, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan